BATS BZX Real-Time Price
As of 1:55pm ET
| +0.60 / +1.89%|
The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 42.00, with a high estimate of 65.00 and a low estimate of 32.00. The median estimate represents a +30.07% increase from the last price of 32.29.
The current consensus among 8 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.